Can Encompass Health's Expansion Strategy Drive Its Next Growth Phase?

29.06.26 19:37 Uhr

Werte in diesem Artikel
Aktien

USD 0,00 USD 0,00%

81,79 EUR 8,96 EUR 12,30%

Indizes

29.774,8 PKT 656,5 PKT 2,25%

25.820,1 PKT 522,5 PKT 2,07%

Encompass Health Corporation EHC has reached an interesting point in its growth story. Demand is no longer the primary metric to watch. Supported by an aging U.S. population, the need for inpatient rehabilitation services continues to grow. Now the key question hinges on scale: Can EHC expand capacity fast enough to meet that demand?Many of its hospitals are currently operating at high occupancy levels. To address this, management has changed its strategy. Instead of waiting for facilities to reach near-full capacity, it is now launching expansion projects earlier. This proactive approach brings new beds online before capacity becomes a constraint, helping the company capture more patient referrals.We are already seeing this plan in action. In the first quarter of 2026, EHC opened a new 49-bed hospital in South Carolina and added 44 beds to existing locations. By the end of the year, it plans to open eight more hospitals and add about 175 beds. EHC has 11 additional hospitals in its development pipeline and plans to introduce a smaller hospital design in 2027 to better serve crowded, fast-growing markets.EHC's expansion strategy is beginning to translate into stronger financial performance. First-quarter 2026 revenues rose 9% and adjusted EBITDA increased 11.2%, prompting management to raise its 2026 adjusted EPS guidance to $5.89-$6.11 from $5.81-$6.10. The investment thesis now depends less on demand and more on execution. Successfully bringing new capacity online while maintaining operational efficiency could support sustained earnings growth over the long run.How Are EHC's Peers Positioned?Encompass Health is not alone in expanding capacity to meet rising healthcare demand. Medical sector peers like Select Medical Holdings Corporation SEM and HCA Healthcare, Inc. HCA are also investing in new facilities and hospital expansion to support long-term growth.Select Medical is also expanding its inpatient rehabilitation footprint through new hospitals and joint ventures with health systems. Select Medical continues to strengthen its rehabilitation network to meet rising demand for post-acute care.HCA Healthcare is also expanding its hospital network through new facilities and capacity additions to meet rising healthcare demand. HCA Healthcare continues to invest in its acute-care footprint, reinforcing capacity expansion as a key long-term growth strategy.EHC’s Price Performance, Valuation & EstimatesShares of Encompass Health have lost 4.5% year to date against the industry’s 14.3%. growth.Image Source: Zacks Investment ResearchFrom a valuation standpoint, EHC trades at a forward price-to-earnings ratio of 16.33X compared with the industry average of 18.08X. Encompass Health carries a Value Score of B.Image Source: Zacks Investment ResearchThe Zacks Consensus Estimate for EHC’s 2026 earnings is pegged at $5.97 per share, implying a 9.54% increase from the year-ago period’s level.Image Source: Zacks Investment ResearchEncompass Health currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.See Stocks Now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Strategy (ex MicroStrategy) und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Strategy (ex MicroStrategy)

Analysen zu Strategy (ex MicroStrategy)

DatumRatingAnalyst
11.02.2019Microstrategy A BuyBWS Financial
27.10.2017Microstrategy A BuyMizuho
28.07.2017Microstrategy A HoldDeutsche Bank AG
16.11.2016Microstrategy A BuyMizuho
11.01.2016Microstrateg a BuyDeutsche Bank AG
DatumRatingAnalyst
11.02.2019Microstrategy A BuyBWS Financial
27.10.2017Microstrategy A BuyMizuho
16.11.2016Microstrategy A BuyMizuho
11.01.2016Microstrateg a BuyDeutsche Bank AG
11.12.2015Microstrateg a BuyMizuho
DatumRatingAnalyst
28.07.2017Microstrategy A HoldDeutsche Bank AG
19.10.2015Microstrateg a HoldLake Street
31.10.2012Microstrateg a neutralROTH Capital Partners, LLC
30.10.2012Microstrateg a neutralUBS AG
31.07.2012Microstrateg a neutralUBS AG
DatumRatingAnalyst
16.03.2005Update Microstrategy Inc.: SellWedbush Morgan
09.02.2005Update Microstrategy Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Strategy (ex MicroStrategy) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen